Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samia Mora

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|August 2, 2014
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trialsS Matthijs Boekholdt, G Kees Hovingh, Samia Mora, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Metabolites|October 30, 2020
One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)Olga V Demler, Yanyan Liu, Heike Luttmann-Gibson, et al.
Clinical Chemistry and Laboratory Medicine|December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLMMichel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis|January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLMBørge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular DiseaseAnnabelle Rodriguez, Bernardo L Trigatti, Chieko Mineo, et al.
Atherosclerosis|May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and ManagementFlorian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
Circulation|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Roger S Blumenthal, Pamela B Morris, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|August 2, 2014
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trialsS Matthijs Boekholdt, G Kees Hovingh, Samia Mora, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Atherosclerosis|October 16, 2025
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysisJedidiah I Morton, Florian Kronenberg, Magdalena Daccord, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Metabolites|October 30, 2020
One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: Findings from a Substudy of the Vitamin D and Omega-3 Trial (VITAL)Olga V Demler, Yanyan Liu, Heike Luttmann-Gibson, et al.
Clinical Chemistry and Laboratory Medicine|December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLMMichel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis|January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLMBørge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 11, 2019
Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular DiseaseAnnabelle Rodriguez, Bernardo L Trigatti, Chieko Mineo, et al.
Atherosclerosis|May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and ManagementFlorian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
Circulation|March 13, 2026
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Roger S Blumenthal, Pamela B Morris, et al.
Pageof 26